Total planned funding: $85,428,232
Allocations
Countries/Regions
India | $85,428,232 |
Organizational Types
Unknown | $32,258,000 |
NGO | $21,702,610 |
Own Agency | $18,267,622 |
University | $3,450,000 |
Implementing Agency | $3,100,000 |
FBO | $2,200,000 |
Multi-lateral Agency | $2,200,000 |
Private Contractor | $1,650,000 |
Host Country Government Agency | $600,000 |
Program Areas
Governance and Systems | $37,867,066 |
Prevention | $19,348,420 |
Management and Operations | $13,081,490 |
Care | $7,772,091 |
Treatment | $4,400,714 |
Testing | $2,958,451 |
Budget Codes
OHSS: Health Systems Strengthening | $20,020,561 |
HVMS: Management and Operations | $13,081,490 |
HVSI: Strategic Information | $12,397,036 |
HVOP: Sexual Prevention: Other Sexual Prevention | $10,116,825 |
HLAB: Laboratory Infrastructure | $5,449,469 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,423,004 |
HTXS: Treatment: Adult Treatment | $3,794,313 |
HBHC: Care: Adult Care and Support | $3,367,178 |
HVCT: Testing: HIV Testing and Counseling | $2,958,451 |
HVTB: Care: TB/HIV | $2,711,305 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $1,887,524 |
HMBL: Biomedical Prevention: Blood Safety | $1,869,836 |
HKID: Care: Orphans and Vulnerable Children | $1,490,879 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,051,231 |
PDTX: Treatment: Pediatric Treatment | $582,924 |
PDCS: Care: Pediatric Care and Support | $202,729 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$32,258,000
Countries/Regions
FHI 360:
$13,737,357
Countries/Regions
USG Aggregated Agencies:
$13,151,585
Countries/Regions
University of Washington:
$3,450,000
Countries/Regions